2020
DOI: 10.1016/j.porgcoat.2019.105440
|View full text |Cite
|
Sign up to set email alerts
|

Prolongation of bactericidal efficiency of chitosan — Bioactive glass coating by drug controlled release

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
14
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 58 publications
3
14
0
Order By: Relevance
“…Mass spectrometry was performed by the company to confirm the molecular weight of synthetic Melittin. The peptide concentration and its purity was respectively reconfirmed using bicinchoninic acid assay (BCA) and RP-HPLC as described earlier [ 46 ]. Four µl of Melittin was drop-casted over coatings and dried at ambient conditions for 3 h.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Mass spectrometry was performed by the company to confirm the molecular weight of synthetic Melittin. The peptide concentration and its purity was respectively reconfirmed using bicinchoninic acid assay (BCA) and RP-HPLC as described earlier [ 46 ]. Four µl of Melittin was drop-casted over coatings and dried at ambient conditions for 3 h.…”
Section: Methodsmentioning
confidence: 99%
“…Antimicrobial activity of the specimens was tested against Methicillin-resistant Staphylococcus aureus (MRSA) bacteria strain according to our previous study [ 46 ]. Briefly, MRSA bacteria were cultured overnight.…”
Section: Methodsmentioning
confidence: 99%
“…Vancomycin (Van) is a glycopeptide antibiotic. It has a good antibacterial activity for most Gram-positive bacteria due to the inhibition of the growth and reproduction of bacteria [ 65 , 66 ]. Therefore, Van is widely used to promote implant antibacterial activity and osseointegration capability [ 67 ].…”
Section: Local Drug Delivery Systems With Ti-based Implantsmentioning
confidence: 99%
“…Accordingly, it has been found that the combination of antimicrobial peptides (AMPs) with conventional antibiotics can be a promising strategy against MDR bacterial pathogens (Zusman et al, 2013;Schmid et al, 2019). Currently, AMPs are found as novel developing antibacterial agents that could serve as an alternative to antibiotics (Bardbari et al, 2018;Memariani et al, 2018;Aghazadeh et al, 2019;Akbari et al, 2019;Bevalian et al, 2021;Zarghami et al, 2021a). Furthermore, the application of AMPs along with conventional antibiotics usually enhances the results of mono drug therapies (Bardbari et al, 2018;Akbari et al, 2019).…”
Section: Introductionmentioning
confidence: 99%